Veeva Systems Inc
NYSE:VEEV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Veeva Systems Inc
Gross Profit
Veeva Systems Inc
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Veeva Systems Inc
NYSE:VEEV
|
Gross Profit
$2.4B
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
25%
|
|
|
Teladoc Health Inc
NYSE:TDOC
|
Gross Profit
$1.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
20%
|
CAGR 10-Years
41%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Gross Profit
$778.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Gross Profit
$514.5m
|
CAGR 3-Years
19%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Gross Profit
$508m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Gross Profit
$751.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Veeva Systems Inc
Glance View
Veeva Systems Inc., born in the heart of Silicon Valley in 2007, embarked on its journey with a clear mission: to revolutionize the pharmaceutical and life sciences industries with cloud-based solutions. Founded by Peter Gassner, who previously held leadership roles at Salesforce and PeopleSoft, Veeva identified a niche opportunity amid the highly-regulated, complex landscape of healthcare. The company began by offering Customer Relationship Management (CRM) software tailored for the life sciences sector, allowing clients to stay compliant with industry regulations while efficiently managing relationships across the intricate healthcare network. Veeva’s CRM solutions gradually became instrumental for pharmaceutical and biotech companies in conducting their marketing, sales, and collaboration activities. As Veeva expanded, it diversified its portfolio by delving into other digital solutions, such as data management and analytics, content management, and regulatory and compliance software. Its Vault platform stood out, providing a unified suite for managing a vast array of business processes and content across powerful cloud applications. This approach enabled Veeva to serve its clientele throughout the drug development lifecycle, from research and development to commercialization. By adopting a subscription-based pricing model, Veeva ensured a steady revenue stream while continuously enhancing its offerings, solidifying its position as both a trusted partner and a critical component of its clients’ operational infrastructure. Through these strategic expansions, Veeva Systems Inc. not only adapted to the evolving demands of the healthcare sector but also reinforced its dominance in the specialized domain of life sciences cloud technology.
See Also
What is Veeva Systems Inc's Gross Profit?
Gross Profit
2.4B
USD
Based on the financial report for Jan 31, 2026, Veeva Systems Inc's Gross Profit amounts to 2.4B USD.
What is Veeva Systems Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
25%
Over the last year, the Gross Profit growth was 18%. The average annual Gross Profit growth rates for Veeva Systems Inc have been 16% over the past three years , 18% over the past five years , and 25% over the past ten years .